D. Mérino, et.al., Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression., Oncogene, 2012, 31

http://rdf.ncbi.nlm.nih.gov/pubmed/22081075

D. Mérino, et.al., Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression., Oncogene, 2012, 31

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased T cell derived lymphoma incidence_Bcl2l11<tm1.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002024IC57BL6SJLBcl2l11tm11BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm11BouiTgIghMyc22Bri
• increased B cell derived lymphoma incidence_Bcl2l11<tm1.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BL6SJLBcl2l11tm11BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm11BouiTgIghMyc22Bri
• premature death_Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083IC57BL6SJLTgIghMyc22Bri0TgIghMyc22Bri
• increased leukocyte cell number_Bcl2l11<tm1.1Boui>/Bcl2l11<tm1.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0000218IC57BL6SJLBcl2l11tm11BouiBcl2l11tm11BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm11Boui
• increased leukocyte cell number_Bcl2l11<tm2.1Boui>/Bcl2l11<tm2.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0000218IC57BL6SJLBcl2l11tm21BouiBcl2l11tm21BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm21Boui
• premature death_Bcl2l11<tm2.1Boui>/Bcl2l11<tm2.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083IC57BL6SJLBcl2l11tm21BouiBcl2l11tm21BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm21Boui
• increased B cell derived lymphoma incidence_Bcl2l11<tm3.1Boui>/Bcl2l11<tm3.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BL6SJLBcl2l11tm31BouiBcl2l11tm31BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm31Boui
• increased B cell derived lymphoma incidence_Bcl2l11<tm1.1Boui>/Bcl2l11<tm1.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BL6SJLBcl2l11tm11BouiBcl2l11tm11BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm11Boui
• premature death_Bcl2l11<tm1.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083IC57BL6SJLBcl2l11tm11BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm11BouiTgIghMyc22Bri
• increased B cell derived lymphoma incidence_Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BL6SJLTgIghMyc22Bri0TgIghMyc22Bri
• premature death_Bcl2l11<tm3.1Boui>/Bcl2l11<tm3.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083IC57BL6SJLBcl2l11tm31BouiBcl2l11tm31BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm31Boui
• increased leukocyte cell number_Bcl2l11<tm2.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0000218IC57BL6SJLBcl2l11tm21BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm21BouiTgIghMyc22Bri
• premature death_Bcl2l11<tm1.1Boui>/Bcl2l11<tm1.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083IC57BL6SJLBcl2l11tm11BouiBcl2l11tm11BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm11Boui
• increased leukocyte cell number_Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0000218IC57BL6SJLTgIghMyc22Bri0TgIghMyc22Bri
• increased B cell derived lymphoma incidence_Bcl2l11<tm3.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BL6SJLBcl2l11tm31BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm31BouiTgIghMyc22Bri
• premature death_Bcl2l11<tm2.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083IC57BL6SJLBcl2l11tm21BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm21BouiTgIghMyc22Bri
• increased leukocyte cell number_Bcl2l11<tm1.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0000218IC57BL6SJLBcl2l11tm11BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm11BouiTgIghMyc22Bri
• increased B cell derived lymphoma incidence_Bcl2l11<tm2.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BL6SJLBcl2l11tm21BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm21BouiTgIghMyc22Bri
• increased B cell derived lymphoma incidence_Bcl2l11<tm2.1Boui>/Bcl2l11<tm2.1Boui>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002023IC57BL6SJLBcl2l11tm21BouiBcl2l11tm21BouiTgIghMyc22Bri0TgIghMyc22BriBcl2l11tm21Boui
• premature death_Bcl2l11<tm3.1Boui>/Bcl2l11<+>,Tg(IghMyc)22Bri/0
  http://metadb.riken.jp/0002083IC57BL6SJLBcl2l11tm31BouiBcl2l11TgIghMyc22Bri0Bcl2l11Bcl2l11tm31BouiTgIghMyc22Bri